Where Centessa Pharmaceuticals Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on Centessa Pharmaceuticals (NASDAQ:CNTA) stock. The average price target for the stock is $10.0, with a high of $15.00 and a low of $5.00. The average price target has increased by 31.23% over the past month.
August 15, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a positive outlook on Centessa Pharmaceuticals (NASDAQ:CNTA) with an average price target of $10.0.
The average price target for Centessa Pharmaceuticals has increased by 31.23% over the past month, indicating a positive sentiment among analysts. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100